Cardiology
There is no content available at this time. Please check again later.
Relevant Content
Deprescribing in Patients With Cardiovascular Disease Experiencing Polypharmacy
What is VTE: Why Does it Matter?
Adjunctive Normobaric Hyperoxia With Endovascular Thrombectomy for Acute Stroke at 6 to 24 Hours: A Phase IIb Randomized Trial
Polypharmacy is common in cardiovascular (CV) care because guideline-direc...
Transforming VTE Care: From Risk Identification to Protocol Implementation
Stroke, Ahead of Print.
BACKGROUND:Normobaric hyperoxia (NBO) is a si...
Paclitaxel-Coated Balloon Versus Uncoated Balloon for Coronary In-Stent Restenosis: Two-Year Follow-Up of the AGENT-IDE Randomized Clinical Trial
BACKGROUND:Normobaric hyperoxia (NBO) is a si...
Circulation, Volume 154, Issue 1, Page 63-65, July 7, 2026.
A New Circulation, For You
Circulation, Volume 154, Issue 1, Page 4-6, July 7, 2026.
Cardiovascular Risk Reduction With GLP-1 RA Drugs
Circulation, Volume 154, Issue 1, Page 66-73, July 7, 2026.
GLP-1 (gl...
Physical Activity for Weight Loss and Health Promotion
GLP-1 (gl...
Circulation, Volume 154, Issue 1, Page 82-84, July 7, 2026.
Proteomics‐Based Soluble Urokinase Plasminogen Activator Receptor Levels Are Associated With Adverse Cardiovascular Outcomes in the General Population: Insights From the UK Biobank
Journal of the American Heart Association, Ahead of Print.
Background...
Graded Associations Between Left Ventricular Ejection Fraction Improvement and Cardiorenal Outcomes in Heart Failure With Improved Ejection Fraction
Background...
Journal of the American Heart Association, Ahead of Print.
Background...
Background...